Veracyte
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $114,428 | $96,844 | $98,199 | $90,108 |
Gross Profit | 75,785 | 60,525 | 63,153 | 62,498 |
EBITDA | 10,444 | 1,363 | 4,912 | 45,384 |
EBIT | 4,706 | -4,227 | -1,424 | 38,062 |
Net Income | 5,734 | -1,864 | -28,293 | -29,618 |
Net Change In Cash | 114,428 | 96,844 | 98,199 | 90,108 |
Free Cash Flow | 26,805 | -11,100 | 13,055 | 11,369 |
Cash | 235,915 | 209,188 | 216,454 | 202,463 |
Basic Shares | 77,163 | 74,759 | 73,107 | 72,804 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $361,051 | $296,536 | $219,514 | $117,483 |
Gross Profit | 223,152 | 194,954 | 145,114 | 76,028 |
EBITDA | 15,125 | -15,153 | -62,310 | -26,736 |
EBIT | -12,063 | -44,401 | -83,535 | -35,644 |
Net Income | -74,404 | -36,560 | -75,563 | -35,847 |
Net Change In Cash | 361,051 | 296,536 | 219,514 | 117,483 |
Cost of Revenue | -18,358 | -174,507 | 190,047 | |
Free Cash Flow | 34,261 | -1,014 | -36,997 | -12,548 |
Cash | 216,454 | 154,247 | 173,197 | 349,364 |
Basic Shares | 72,644 | 71,549 | 67,890 | 53,239 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.07 |
2024-03-31 | -$0.02 |
2023-12-31 | -$0.39 |
2023-09-30 | -$0.41 |
